- ►annals.org [PDF] TH Jafar, CH Schmid, M Landa, I Giatras, R … - Annals of internal medicine, 2001 - Am Coll Physicians Tazeen H. Jafar, MD, MPH; Christopher H. Schmid, PhD; Marcia Landa, MA; Ioannis
Giatras, MD; Robert Toto, MD; Giuseppe Remuzzi, MD; Giuseppe Maschio, MD; Barry
M. Brenner, MD; Annelise Kamper, MD; Pietro Zucchelli, MD; Gavin Becker, ... Cited by 531 - Related articles - BL Direct - All 4 versions
AI Adler, RJ Stevens, SE Manley, RW Bilous, … - Kidney international, 2003 - nature.com The progression of nephropathy from diagnosis of type 2 diabetes has not been
well described from a single population. This study sought to describe the
development and progression through the stages of microalbuminuria, ... Cited by 387 - Related articles - BL Direct - All 4 versions
AM El Nahas, AK Bello - The Lancet, 2005 - Elsevier The worldwide rise in the number of patients with chronic kidney disease (CKD)
and consequent end-stage renal failure necessitating renal replacement therapy
is threatening to reach epidemic proportions over the next decade, and only ... Cited by 224 - Related articles - All 6 versions
L Boulware, BG Jaar, ME Tarver-Carr, FL … - Jama, 2003 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Chronic kidney ... Cited by 148 - Related articles - BL Direct - All 10 versions
KR Chapman, DM Mannino, JB Soriano, PA … - European Respiratory Journal, 2006 - ersj.org.uk Chronic obstructive pulmonary disease (COPD) is a leading but under-recognised
cause of morbidity and mortality worldwide 1. The prevalence of COPD in the
general population is estimated to be 1% across all ages rising steeply to ... Cited by 139 - Related articles - BL Direct - All 6 versions
- ►asnjournals.org M Tonelli, L Moye, FM Sacks, T Cole, GC … - Journal of the American Society of Nephrology, 2003 - Am Soc Nephrol Hyperlipidemia has been hypothesized to play an important role in the
progression of renal insufficiency, either through toxic effects of lipids on
mesangial cells or by promoting intrarenal atherosclerosis (8–10). In ... Cited by 126 - Related articles - BL Direct - All 7 versions
- ►asnjournals.org AR NISSENSON, AJ COLLINS, J Hurley, H … - Journal of the American Society of Nephrology, 2001 - Am Soc Nephrol Abstract. There are between 2 and 13 million Americans with chronic kidney
disease (CKD). Recent reports suggest that their treatment is currently
suboptimal. To further investigate this issue, patterns of practice for the ... Cited by 117 - Related articles - BL Direct - All 6 versions
PWF Wilson - Endocrinology and metabolism clinics of North America, 2001 - Elsevier Although mortality from coronary heart disease (CHD) has declined during the
past several decades in North America, a commensurate decrease in the incidence
of coronary disease has not happened, and the United States and other ... Cited by 110 - Related articles - BL Direct - All 7 versions
AJ Palmer, S Roze, WJ Valentine, ME … - Current Medical Research and Opinion®, 2004 - informahealthcare.com Objectives: We have developed an Internet-based, interactive computer model to
determine the long- term health outcomes and economic consequences of
implementing different treatment policies or interventions in type 1 and ... Cited by 110 - Related articles - BL Direct - All 6 versions
TH Hostetter - The New England Journal of Medicine, 2001 - nejm.highwire.org The prevalence of end-stage renal disease is increasing at an alarming rate. In
2000, chronic kidney failure developed in over 90,000 people in the United
States; the current population of patients on dialysis numbers about ... Cited by 104 - Related articles - BL Direct - All 4 versions
